These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16414995)

  • 1. Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression.
    Nelson HB; Tang H
    J Virol; 2006 Feb; 80(3):1181-90. PubMed ID: 16414995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobility analysis of an NS5A-GFP fusion protein in cells actively replicating hepatitis C virus subgenomic RNA.
    Jones DM; Gretton SN; McLauchlan J; Targett-Adams P
    J Gen Virol; 2007 Feb; 88(Pt 2):470-475. PubMed ID: 17251564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of subgenomic hepatitis C virus replicon RNA levels in Huh-7 cells after exposure to nucleoside antimetabolites.
    Stuyver LJ; McBrayer TR; Tharnish PM; Hassan AE; Chu CK; Pankiewicz KW; Watanabe KA; Schinazi RF; Otto MJ
    J Virol; 2003 Oct; 77(19):10689-94. PubMed ID: 12970456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells.
    Lee JC; Chang CF; Chi YH; Hwang DR; Hsu JT
    J Virol Methods; 2004 Mar; 116(1):27-33. PubMed ID: 14715304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome.
    Takigawa Y; Nagano-Fujii M; Deng L; Hidajat R; Tanaka M; Mizuta H; Hotta H
    Microbiol Immunol; 2004; 48(8):591-8. PubMed ID: 15322339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors.
    Korf M; Jarczak D; Beger C; Manns MP; Krüger M
    J Hepatol; 2005 Aug; 43(2):225-34. PubMed ID: 15964661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricistronic hepatitis C virus subgenomic replicon expressing double transgenes.
    Cheng X; Gao XC; Wang JP; Yang XY; Wang Y; Li BS; Kang FB; Li HJ; Nan YM; Sun DX
    World J Gastroenterol; 2014 Dec; 20(48):18284-95. PubMed ID: 25561795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HCV replication by cyclophilin antagonists is linked to replication fitness and occurs by inhibition of membranous web formation.
    Madan V; Paul D; Lohmann V; Bartenschlager R
    Gastroenterology; 2014 May; 146(5):1361-72.e1-9. PubMed ID: 24486951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture.
    Klumpp K; Lévêque V; Le Pogam S; Ma H; Jiang WR; Kang H; Granycome C; Singer M; Laxton C; Hang JQ; Sarma K; Smith DB; Heindl D; Hobbs CJ; Merrett JH; Symons J; Cammack N; Martin JA; Devos R; Nájera I
    J Biol Chem; 2006 Feb; 281(7):3793-9. PubMed ID: 16316989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon.
    Shimakami T; Hijikata M; Luo H; Ma YY; Kaneko S; Shimotohno K; Murakami S
    J Virol; 2004 Mar; 78(6):2738-48. PubMed ID: 14990694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes.
    Moradpour D; Evans MJ; Gosert R; Yuan Z; Blum HE; Goff SP; Lindenbach BD; Rice CM
    J Virol; 2004 Jul; 78(14):7400-9. PubMed ID: 15220413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
    Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
    MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Let-7b is a novel regulator of hepatitis C virus replication.
    Cheng JC; Yeh YJ; Tseng CP; Hsu SD; Chang YL; Sakamoto N; Huang HD
    Cell Mol Life Sci; 2012 Aug; 69(15):2621-33. PubMed ID: 22391672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant negative effect of wild-type NS5A on NS5A-adapted subgenomic hepatitis C virus RNA replicon.
    Graziani R; Paonessa G
    J Gen Virol; 2004 Jul; 85(Pt 7):1867-1875. PubMed ID: 15218171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of 2'-substituted nucleosides on hepatitis C virus replication correlates with metabolic properties in replicon cells.
    Tomassini JE; Getty K; Stahlhut MW; Shim S; Bhat B; Eldrup AB; Prakash TP; Carroll SS; Flores O; MacCoss M; McMasters DR; Migliaccio G; Olsen DB
    Antimicrob Agents Chemother; 2005 May; 49(5):2050-8. PubMed ID: 15855531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma xenograft supports HCV replication: a mouse model for evaluating antivirals.
    Hazari S; Hefler HJ; Chandra PK; Poat B; Gunduz F; Ooms T; Wu T; Balart LA; Dash S
    World J Gastroenterol; 2011 Jan; 17(3):300-12. PubMed ID: 21253388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C-terminal transmembrane domain of hepatitis C virus (HCV) RNA polymerase is essential for HCV replication in vivo.
    Lee KJ; Choi J; Ou JH; Lai MM
    J Virol; 2004 Apr; 78(7):3797-802. PubMed ID: 15016899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C Virus.
    Fillebeen C; Rivas-Estilla AM; Bisaillon M; Ponka P; Muckenthaler M; Hentze MW; Koromilas AE; Pantopoulos K
    J Biol Chem; 2005 Mar; 280(10):9049-57. PubMed ID: 15637067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance analysis and characterization of NITD008 as an adenosine analog inhibitor against hepatitis C virus.
    Qing J; Luo R; Wang Y; Nong J; Wu M; Shao Y; Tang R; Yu X; Yin Z; Sun Y
    Antiviral Res; 2016 Feb; 126():43-54. PubMed ID: 26724382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.